Resveratrol attenuates T-2 toxin-induced pro-inflammatory microglial activation via the BTG2-regulated TLR4/MyD88/NF-κB pathway.
Novel evidence is provided that Res may target the BTG2-regulated TLR4/MyD88/NF-κB signal pathway to exert neuroprotection, providing a promising intervention option for reducing the environmental and health hazards associated with exposure to T-2 toxin.